The aim of the study is to investigate the measurements obtained from the preoperative contrast-enhanced both computed tomography (CT) and magnetic resonance imaging (MRI) with pathologic specimen in measuring the size of pancreatic cancer. It was found in this study, both contrast-enhanced CT and MRI underestimate mean tumor size by 3.3 mm and 4.7 mm respectively, when compared with the size of pathologic specimen.
This abstract and the presentation materials are available to members only; a login is required.